Bionano Genomics Inc
NASDAQ:BNGO
Bionano Genomics Inc
NASDAQ:BNGO
Price:
1.15
USD
2.68%
Market Closed
Market Cap:
$11.7m
Relative Value
There is not enough data to reliably calculate the relative value of BNGO.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BNGO
Relative Value
Base Case
Not Available
Multiples Across Competitors
BNGO Competitors Multiples
Bionano Genomics Inc Competitors
Bionano Genomics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Bionano Genomics Inc
NASDAQ:BNGO
|
11.2m USD | 0.4 | -0.3 | 0.3 | 0.2 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
947.7B USD | 331.8 | 3 929 | 1 125.9 | 2 168.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
178.5B USD | 4 | 26.6 | 18.6 | 24.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
133.9B USD | 5.4 | 37 | 18.9 | 27.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
32.5B CHF | 4.9 | 34.1 | 25.5 | 25.5 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
266.5B CNY | 6 | 17.8 | 17.8 | 17.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.5B USD | 4.5 | 24.4 | 18 | 21.2 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.3B USD | 9.3 | 45.6 | 29.5 | 37 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.2B USD | 1.7 | 20.8 | 11.7 | 17.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.5B USD | 6.1 | 28.2 | 21 | 23.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
